Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical and Local TXA in Facelifts
NCT06345833Phase 1Withdrawn
- Sponsor
- University of Minnesota
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tranexamic acid in hemorrhage (3 arms), sponsored by University of Minnesota. Primary endpoint: Blood loss at 2 weeks. Planned start Jul 2024; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT06345833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06345833.